MedPath

Obstructive Sleep Apnoea (OSA) in patients with type 2 diabetes and the effect of continuous positive airway pressure (CPAP) treatment on diabetic control, insulin resistance and blood pressure

Completed
Conditions
OSA and coexisting Type 2 diabetes
Nervous System Diseases
Sleep apnoea
Registration Number
ISRCTN28644636
Lead Sponsor
Diabetes UK
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
40
Inclusion Criteria

1. Age 18-75
2. Type 2 diabetes
3. OSA with more than 10 >4% SaO2 dips per hour on sleep study
4. Epworth Sleepiness Score >9

Exclusion Criteria

1. Unstable diabetes
2. Respiratory failure requiring urgent nocturnal ventilation

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1c% change
Secondary Outcome Measures
NameTimeMethod
Insulin resistance measured by euglycaemic clamp and homeostatic model assessment, blood pressure
© Copyright 2025. All Rights Reserved by MedPath